US Patent 9206251 Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics
Patent 9206251 was granted and assigned to Alexion Pharmaceuticals, Inc. on December, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9206251 Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
